Strategic Partnership Highlights Cybersecurity in Telemedicine and Sends Shares Higher

Sponsored:

Monday, December 23, 2024

Cybersecurity is critical to the success of digital therapeutics. With telemedicine and remote patient monitoring now central to modern healthcare, protecting sensitive patient data is essential for building trust, ensuring effective treatment, and preserving platform reliability. This micro cap company is unlocking digital therapeutics' transformative potential.

Quantum eMotion Corp. (TSX-Venture: QNC) (OTCQB: QNCCF), a leader in classical and quantum-based cybersecurity solutions, announced in a press release today that it has reached a significant milestone with the commercialization of its cloud-based Sentry-Q platform. Designed to address critical cybersecurity challenges in telemedicine and digital healthcare, the platform is integral to a strategic partnership between GreyBox Solutions, a leader in digital therapeutics (DTx), and Becton Dickinson (BD), a global medical device and diagnostics giant with over $20 billion in annual sales. This collaboration focuses on advancing remote patient monitoring to improve the quality of life for patients with chronic diseases while enabling clinicians to manage multiple patients efficiently. The initiative will initially launch in Canada, with plans to expand into the USA and potentially global markets.  

Building on their partnership established in 2023, QeM and GreyBox continue to enhance the cybersecurity framework of GreyBox's DTx platform using a revenue-sharing business model. QeM's Sentry-Q platform plays a vital role in protecting patient data, ensuring treatment accuracy, and maintaining platform reliability—key components for success in the digital therapeutics sector. This collaboration underscores the importance of robust cybersecurity in the rapidly evolving telemedicine and healthcare landscape.

Shares of QNC are up over 20% in early-afternoon trading as investors applaud the partnership announcement. 

Sponsored: